Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview
Insha Zahoor, Bin Rui, Junaid Khan, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 7, pp. 3181-3203
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Cytochrome P450 Enzymes and Drug Metabolism in Humans
Mingzhe Zhao, Jingsong Ma, Mo Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12808-12808
Open Access | Times Cited: 534
Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases
Yiheng Chen, Tianyuan Lu, U. Pettersson, et al.
Nature Genetics (2023) Vol. 55, Iss. 1, pp. 44-53
Open Access | Times Cited: 422
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course
Xiaoyuan Zhou, Ryan Baumann, Xiaohui Gao, et al.
Cell (2022) Vol. 185, Iss. 19, pp. 3467-3486.e16
Open Access | Times Cited: 186
Current and Future Biomarkers in Multiple Sclerosis
Jennifer Yang, Maysa Hamade, Qi Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5877-5877
Open Access | Times Cited: 91
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
Insha Zahoor, Hamid Suhail, Indrani Datta, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 25
Open Access | Times Cited: 38
Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis
Eneritz López-Muguruza, Carlos Matute
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12912-12912
Open Access | Times Cited: 34
The toxic metal hypothesis for neurological disorders
Roger Pamphlett, David Bishop
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 16
Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity
Alexandra E. Oppong, Leda Coelewij, G S M Robertson, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109225-109225
Open Access | Times Cited: 7
Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet
Theresa L. Montgomery, Daniel Peipert, Dimitry N. Krementsov
Immunological Reviews (2024) Vol. 325, Iss. 1, pp. 131-151
Open Access | Times Cited: 6
New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration
Maria Podbielska, Joan O’Keeffe, Anna Pokryszko−Dragan
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7319-7319
Open Access | Times Cited: 37
Isoflavone consumption reduces inflammation through modulation of phenylalanine and lipid metabolism
Rachel L. Shrode, Nicole Cady, Samantha N. Jensen, et al.
Metabolomics (2022) Vol. 18, Iss. 11
Open Access | Times Cited: 23
Design, synthesis, SAR and ADMET analyses of the novel class of synthetic 7-amino[1,2,5]oxadiazolo[3,4-b]pyridine-6-carboxylate derivatives with vasorelaxant activity
Anatolii Varenyk, R. N. Vydzhak, S. Ya. Panchishin, et al.
Results in Chemistry (2025), pp. 102031-102031
Open Access
Alzheimer's disease (AD) in multiple sclerosis (MS): A systematic review of published cases, mechanistic links between AD and MS, and possible clinical evaluation of AD in MS
Ross Cottrill, Anupa Ekanayake, Cooper Grove, et al.
Journal of Alzheimer s Disease Reports (2025) Vol. 9
Open Access
Changes in the metabolome, lipidomein, and gut microbiota in behcet disease
Shang Chen, Sujuan Ji, W. Hao, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Metabolomics of ischemic stroke: insights into risk prediction and mechanisms
Ruijie Zhang, Jiajia Meng, Xiaojie Wang, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 7, pp. 2163-2180
Closed Access | Times Cited: 19
Metabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis
Naeun Yoon, Ah-kyung Jang, Yerim Seo, et al.
Metabolites (2021) Vol. 11, Iss. 12, pp. 812-812
Open Access | Times Cited: 23
Biological Markers in Early Multiple Sclerosis: the Paved Way for Radiologically Isolated Syndrome
Manon Rival, Manon Galoppin, Éric Thouvenot
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Sphingolipid Players in Multiple Sclerosis: Their Influence on the Initiation and Course of the Disease
Maria Podbielska, Toshio Ariga, Anna Pokryszko−Dragan
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5330-5330
Open Access | Times Cited: 16
Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosis
Indrani Datta, Insha Zahoor, Nasar Ata, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Potential Metabolite Biomarkers of Multiple Sclerosis from Multiple Biofluids
Fatema Bhinderwala, Heidi E. Roth, Mary L. Filipi, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 6, pp. 1110-1124
Closed Access | Times Cited: 3
The Immunometabolic Gene N-Acetylglucosamine Kinase Is Uniquely Involved in the Heritability of Multiple Sclerosis Severity
Serge Nataf, Marine Guillen, Laurent Pays
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3803-3803
Open Access | Times Cited: 3
Increased cholesterol synthesis drives neurotoxicity in patient stem cell-derived model of multiple sclerosis
Rosana-Bristena Ionescu, Alexandra M. Nicaise, Julie A. Reisz, et al.
Cell stem cell (2024) Vol. 31, Iss. 11, pp. 1574-1590.e11
Open Access | Times Cited: 3
Sphingolipid Catabolism and Glycerophospholipid Levels Are Altered in Erythrocytes and Plasma from Multiple Sclerosis Patients
Albena Momchilova, Roumen Pankov, A. Alexandrov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7592-7592
Open Access | Times Cited: 14
Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients
Insha Zahoor, Jeffrey Waters, Nasar Ata, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis
Rosana-Bristena Ionescu, Alexandra M. Nicaise, Julie A. Reisz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top